Veracyte Statistics
Share Statistics
Veracyte has 78.31M
shares outstanding. The number of shares has increased by 1.96%
in one year.
| Shares Outstanding | 78.31M |
| Shares Change (YoY) | 1.96% |
| Shares Change (QoQ) | 0.57% |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 100 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 5.21M, so 6.66% of the outstanding
shares have been sold short.
| Short Interest | 5.21M |
| Short % of Shares Out | 6.66% |
| Short % of Float | 7.43% |
| Short Ratio (days to cover) | 3.88 |
Valuation Ratios
The PE ratio is 125.48 and the forward
PE ratio is 37.1.
Veracyte's PEG ratio is
-0.96.
| PE Ratio | 125.48 |
| Forward PE | 37.1 |
| PS Ratio | 6.79 |
| Forward PS | 3.1 |
| PB Ratio | 2.58 |
| P/FCF Ratio | 47.47 |
| PEG Ratio | -0.96 |
Financial Ratio HistoryEnterprise Valuation
Veracyte has an Enterprise Value (EV) of 2.84B.
| EV / Sales | 6.37 |
| EV / EBITDA | 57.73 |
| EV / EBIT | 37.82 |
| EV / FCF | 44.51 |
Financial Position
The company has a current ratio of 4.73,
with a Debt / Equity ratio of 0.04.
| Current Ratio | 4.73 |
| Quick Ratio | 4.46 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 1.03 |
| Debt / FCF | 0.8 |
| Interest Coverage | 8071 |
Financial Efficiency
Return on Equity is 2.05% and Return on Invested Capital is 1.19%.
| Return on Equity | 2.05% |
| Return on Assets | 1.86% |
| Return on Invested Capital | 1.19% |
| Revenue Per Employee | $540,975.73 |
| Profits Per Employee | $29,293.69 |
| Employee Count | 824 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 6.79 |
Taxes
| Income Tax | 1.61M |
| Effective Tax Rate | 6.24% |
Stock Price Statistics
The stock price has increased by 24.38% in the
last 52 weeks. The beta is 2.15, so Veracyte's
price volatility has been higher than the market average.
| Beta | 2.15 |
| 52-Week Price Change | 24.38% |
| 50-Day Moving Average | 29.96 |
| 200-Day Moving Average | 35.24 |
| Relative Strength Index (RSI) | 35.46 |
| Average Volume (20 Days) | 1,035,706 |
Income Statement
In the last 12 months, Veracyte had revenue of 445.76M
and earned 24.14M
in profits. Earnings per share was 0.31.
| Revenue | 445.76M |
| Gross Profit | 298.14M |
| Operating Income | 16.14M |
| Net Income | 24.14M |
| EBITDA | 49.2M |
| EBIT | 25.75M |
| Earnings Per Share (EPS) | 0.31 |
Full Income StatementBalance Sheet
The company has 239.09M in cash and 50.74M in
debt, giving a net cash position of 188.35M.
| Cash & Cash Equivalents | 239.09M |
| Total Debt | 50.74M |
| Net Cash | 188.35M |
| Retained Earnings | -443.98M |
| Total Assets | 1.32B |
| Working Capital | 308.03M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 75.1M
and capital expenditures -11.29M, giving a free cash flow of 63.81M.
| Operating Cash Flow | 75.1M |
| Capital Expenditures | -11.29M |
| Free Cash Flow | 63.81M |
| FCF Per Share | 0.83 |
Full Cash Flow StatementMargins
Gross margin is 66.88%, with operating and profit margins of 3.62% and 5.41%.
| Gross Margin | 66.88% |
| Operating Margin | 3.62% |
| Pretax Margin | 5.78% |
| Profit Margin | 5.41% |
| EBITDA Margin | 11.04% |
| EBIT Margin | 3.62% |
| FCF Margin | 14.31% |
